{"id":4123,"date":"2020-05-22T17:25:46","date_gmt":"2020-05-22T15:25:46","guid":{"rendered":"https:\/\/encore-expertisecentrum.nl\/?page_id=4123"},"modified":"2020-11-11T14:40:42","modified_gmt":"2020-11-11T13:40:42","slug":"call-for-participants","status":"publish","type":"page","link":"https:\/\/encore-expertisecentrum.nl\/en\/call-for-participants\/","title":{"rendered":"Participate in clinical studies"},"content":{"rendered":"[vc_row css=”.vc_custom_1590161215645{margin-top: 30px !important;}”][vc_column offset=”vc_col-lg-12 vc_col-md-12″][vc_column_text]
\"\"<\/figure><\/a><\/div>

Kick-off for SYNGAP1 study in adults!<\/a><\/h2>
Participate in our research and contribute to medical knowledge about SYNGAP1 syndrome!<\/div><\/div>
September 23, 2024<\/span><\/div><\/div><\/article>
\"\"<\/figure><\/a><\/div>

DRUP study has started! Patients with Dup15q wanted.<\/a><\/h2>
We invite parents of children with Dup15q syndrome to participate in an important study aimed at identifying the signs and symptoms of this genetic disorder in the Netherlands. <\/div><\/div>
January 11, 2024<\/span><\/div><\/div><\/article>
\"\"<\/figure><\/a><\/div>

UNIEK study started! \u2013 Participants wanted<\/a><\/h2>
The UNIEK study started in April 2023. Within this study, we are conducting research into people who have been found to have a rare genetic variant and who have been diagnosed with an autism spectrum disorder (ASD). We are looking for participants! Do you want to participate?<\/div><\/div>
May 9, 2023<\/span><\/div><\/div><\/article>
\"\"<\/figure><\/a><\/div>

ZEN study<\/a><\/h2>
Met de ZEN studie proberen we te onderzoeken of hoge resolutie zenuwechografie gebruikt kan worden voor het onderzoeken van de zenuwen van mensen met neurofibromatose type 1. Ook onderzoeken we of we veranderingen over de tijd kunnen meten.<\/div><\/div>
January 26, 2023<\/span><\/div><\/div><\/article>
<\/div><\/div>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_toggle title=”Afgeronde klinische studies (deelname gesloten)” style=”square_outline” css=”.vc_custom_1605101999758{margin-top: 30px !important;}”]
\"\"<\/figure><\/a><\/div>

Honeycomb study for GRIN patients started!<\/a><\/h2>
In September 2023, the GRIN expertise center started the Honeycomb study of GRIN Therapeutics.<\/div><\/div>
January 11, 2024<\/span><\/div><\/div><\/article>
\"\"<\/figure><\/a><\/div>

Research into the use of the drug Gaboxadol in children with Angelman Syndrome completed<\/a><\/h2>
\n

In 2019 and 2020, we participated in an international study with the ENCORE expertise center for Angelman Syndrome into the effect of the drug gaboxadol in children with Angelman Syndrome. This is a drug that stimulates the GABA delta receptor. Dutch children also participated. <\/p>\n\n\n\n

In a previous study in which all participants received gaboxadol, clear positive effects were measured on daily functioning. In the current study, a lottery was done between gabaxadol and placebo. The results showed an improvement in both the children who received placebo and those who received gabaxadol. So there was no improvement with the gabaxadol. There were also no serious side effects. This again shows that a study with a placebo group is really important to know for sure whether a treatment is effective. <\/p>\n\n\n\n

We thank the participants and their parents. The article with all the results has now been published. Click here to read the article <\/a>(link valid until October 15)<\/p>\n\n\n\n

<\/p>\n<\/div><\/div>

August 29, 2023<\/span><\/div><\/div><\/article>
\"\"<\/figure><\/a><\/div>

ZEN study<\/a><\/h2>
Met de ZEN studie proberen we te onderzoeken of hoge resolutie zenuwechografie gebruikt kan worden voor het onderzoeken van de zenuwen van mensen met neurofibromatose type 1. Ook onderzoeken we of we veranderingen over de tijd kunnen meten.<\/div><\/div>
January 26, 2023<\/span><\/div><\/div><\/article>
\"\"<\/figure><\/a><\/div>

Tot nader bericht vol – Roche Tangelo studie open voor inclusie van kinderen in ENCORE Angelman syndroom expertisecentrum van Erasmus MC<\/a><\/h2>
Roche's study into a treatment for Angelman Syndrome has been approved by the medical ethics committee (CCMO and METC), which means that Dutch children with Angelman syndrome can now also participate. <\/div><\/div>
December 23, 2020<\/span><\/div><\/div><\/article>
\"\"<\/figure><\/a><\/div>

NEPTUNE TRIAL<\/a><\/h2>
Phase 3 clinical study of the effect of the drug OV101 (Gaboxadol) in children with Angelman Syndrome<\/div><\/div>
November 11, 2020<\/span><\/div><\/div><\/article>
\"\"<\/figure><\/a><\/div>

EXCEL TRIAL<\/a><\/h2>
Phase 2 and 3 clinical study of the effect of Lamotrigine on cognition in patients with NF1<\/div><\/div>
November 11, 2020<\/span><\/div><\/div><\/article>
\"\"<\/figure><\/a><\/div>

COVANT STUDY<\/a><\/h2>
Cognitive variability in NF1 and TSC monozygotic twins<\/div><\/div>
November 11, 2020<\/span><\/div><\/div><\/article>
\"\"<\/figure><\/a><\/div>

GWPCARE6 TRIAL<\/a><\/h2>
Phase 3 clinical study of the effect of Cannabidiol on epilepsy in patients with TSC<\/div><\/div>
November 11, 2020<\/span><\/div><\/div><\/article>
\"\"<\/figure><\/a><\/div>

RAPIT TRIAL<\/a><\/h2>
Phase 2 and 3 clinical study of the effect of the drug Sirolimus in children with TSC.<\/div><\/div>
November 11, 2019<\/span><\/div><\/div><\/article>
\"\"<\/figure><\/a><\/div>

RATE TRIAL<\/a><\/h2>
Fase 2 en 3 klinische studie naar het effect van het medicijn Sirolimus in kinderen met TSC.<\/div><\/div>
November 11, 2016<\/span><\/div><\/div><\/article>
\"\"<\/figure><\/a><\/div>

SIMCODA TRIAL<\/a><\/h2>
Phase 3 clinical study of the effect of the drug Simvastatin in children with NF1<\/div><\/div>
November 11, 2013<\/span><\/div><\/div><\/article>
\"\"<\/figure><\/a><\/div>

NFSIMVA TRIAL<\/a><\/h2>
Phase 3 clinical study of the effect of the drug Simvastatin in patients with NF1<\/div><\/div>
November 11, 2008<\/span><\/div><\/div><\/article>
<\/div><\/div>[\/vc_toggle][\/vc_column][\/vc_row]","protected":false},"excerpt":{"rendered":"

[vc_row css=”.vc_custom_1590161215645{margin-top: 30px !important;}”][vc_column offset=”vc_col-lg-12 vc_col-md-12″][vc_column_text][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_toggle title=”Afgeronde klinische studies (deelname gesloten)” style=”square_outline” css=”.vc_custom_1605101999758{margin-top: 30px !important;}”][\/vc_toggle][\/vc_column][\/vc_row]<\/p>","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/pages\/4123"}],"collection":[{"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/comments?post=4123"}],"version-history":[{"count":15,"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/pages\/4123\/revisions"}],"predecessor-version":[{"id":4670,"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/pages\/4123\/revisions\/4670"}],"wp:attachment":[{"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/media?parent=4123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}